← Back to news

Markets

Trump nominates new BLS head after report says 11K manufacturing jobs lost in July

Y

Is Wall Street Bullish or Bearish on Welltower Stock?

Y

Ethereum treasury company Bitmine Immersion plans to issue $20 billion worth of stock to buy more ETH

Y

Broadcom Stock: Is Wall Street Bullish or Bearish?

Y

Are Wall Street Analysts Bullish on Erie Indemnity Stock?

Y

Goldman Sachs Upgrades Lloyds Banking Group (LYG) to a ‘Buy’ on Improving Fundamentals

Y

S&P Global Ratings Upgrades ADT Inc. (ADT) on Credit Rating and Ownership Improvements

Y

Nomura Holdings (NMR) Q2 Results Top Estimates on Equity Trading Boom

Y

ICL Group Ltd (ICL) Delivers Strong Q2 Results as Sales Hit $1.8B

Y

Banco Santander Brasil SA ADR (BSBR) Net Profit Surges 9.8%

Y

Mizuho Financial Group (MFG) Raises 2025 Guidance on Booming Business

Y

Berentzen appeals ruling on bottle design

Y

Eshbal Functional Foods seeks to triple revenue through North America access

Y

Dow Stock Outlook: Is Wall Street Bullish or Bearish?

Y

Hubbell Expands Grid Infrastructure Capabilities With DMC Power Deal

Y

NXP Semiconductors Stock: Analyst Estimates & Ratings

Y

The Retirement Account That Could Cut Your Taxes — Forever, According to a CFP

Y

Tax Refunds Will Trigger Inflation Next Year, Kelly Says

Y

This Defense Stock Soars on Unusual Upgrade and Earnings

Y

McDonald's Stock Outlook: Is Wall Street Bullish or Bearish?

Y

TSMC to phase out 6-inch wafer production over two years

Y

The Achilles Heel Of This Market Is Back

S

Why Elon Musk is threatening to sue Apple over Grok's App Store ranking

Y

Do Wall Street Analysts Like DaVita Stock?

Y

H.C. Wainwright Reiterates a Buy Rating on Rigel Pharmaceuticals (RIGL), Sets a $57 PT

Y

Needham Maintains a Buy Rating on CorMedix (CRMD) With a $20 PT

Y

Barclays Maintains a Sell Rating on Puma Biotechnology (PBYI) With a $2 PT

Y

William Blair Remains Bullish on Genmab A/S (GMAB)

Y

Soluna expands partnership with Galaxy Digital to scale bitcoin mining

Y

H.C. Wainwright Lifts PT on Halozyme Therapeutics (HALO) to $75 From $72

Y

Morgan Stanley Maintains a Buy Rating on Royalty Pharma Plc (RPRX) With a $55 PT

Y

Wells Fargo Upgrades Incyte Corporation (INCY) to Overweight From Equal Weight

Y

Leerink Partners Reiterates a Buy Rating on BioMarin Pharmaceutical (BMRN), Sets a PT of $105

Y

Guggenheim Lifts PT on Regeneron Pharmaceuticals (REGN) to $815 From $810

Y

Mizuho Slashes PT on The Hain Celestial Group (HAIN) to $2.50 From $3

Y

Evercore ISI Maintains a Buy Rating on Ambev S.A. (ABEV), Sets a $4 PT

Y

Barclays Lowers PT on Nomad Foods Limited (NOMD) to $18 From $20

Y

Barclays Lowers PT on Coca-Cola FEMSA (KOF) to $100 From $105, Keeps an Overweight Rating

Y

UBS Lowers PT on Helen of Troy Limited (HELE) to $29 From $32, Keeps a Neutral Rating

Y

J.P. Morgan Maintains a Buy Rating on Newell Brands (NWL), Sets a $7 PT

Y

Mizuho Lowers PT on JBS N.V. (JBS) to $22 From $55, Keeps an Outperform Rating

Y

Oppenheimer Slashes PT on Spectrum Brands Holdings (SPB) to $95 From $105

Y

TD Cowen Maintains a Hold Rating on MGP Ingredients (MGPI) With a $30 PT

Y

BRF S.A.’s (NYSE:BRFS) Global Scale Rating Gets Upgraded From “BB” to “BB+” by Standard & Poor’s

Y

US Short-Term Treasuries Gain as Traders Boosts Rate-Cut Bets

Y

Inflation rises by most in six months, stoking tariff-driven price concerns

Y

Roger Federer-Backed Sneaker Maker On Holding Raises Outlook as Sales Soar

Y

Dave Ramsey: 7 Brutally Honest Money Tips To Follow Now

Y

Gold Pares Losses Following Steady Inflation Reading

Y

Proposed deal would bring former Prospect exec back to distressed hospitals

Y